Finally, in silico analyses were performed to predict the interactions between GRg3 and the niosomal phospholipid bilayer, and to evaluate GRg3’s penetration efficiency, providing insights for optimizing its delivery through niosomal formulations for the treatment of AD. The gene discussed is TLE3; the disease is Alzheimer disease.